HPV Infection in Sub-Saharan Africa: Circulating Genotypes, Vaccination Strategies (Single-Dose Versus Two-Dose), and Implications of HIV Co-Infection
Vaccines · 17.11.2026 · 14 (11) · 991
DOI: 10.3390/vaccines14110991 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 17.11.2026. Verfasst von Margaret Gurumani und 2 weiteren Autor:innen. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cervical cancer is a major cause of morbidity and mortality among women in sub-Saharan Africa, where vaccination coverage remains below the World Health Organization target of 90% of girls fully vaccinated by 15 years of age. This narrative review synthesizes evidence on human papillomavirus (HPV) genotype distribution, single-dose versus two-dose vaccination, and the implications of human immunodeficiency virus (HIV) co-infection. Although HPV 16 and HPV 18 remain the predominant oncogenic types, HPV 35, HPV 52, HPV 45, HPV 33, and HPV 58 are reported frequently in sub-Saharan African populations. Consequently, some high-risk infections fall outside bivalent and quadrivalent vaccine coverage, and some detected types remain outside nonavalent vaccine coverage. Randomized trials in Tanzania and Kenya demonstrate durable single-dose immunogenicity through 60 months and vaccine efficacy above 98% against persistent vaccine-type infection through 54 months, respectively. A trial in Costa Rica provides a direct five-year randomized comparison showing non-inferiority of one dose to two doses. Equivalent single-dose efficacy and durability evidence for people living with HIV remains unavailable. These findings support expanded single-dose vaccination in immunocompetent populations alongside multidose pathways for people living with HIV, genotype-specific surveillance, and continued cervical screening.
Zitieren
APA
Gurumani, M., Kouamou, V., & Makadzange, A. T. (2026). HPV Infection in Sub-Saharan Africa: Circulating Genotypes, Vaccination Strategies (Single-Dose Versus Two-Dose), and Implications of HIV Co-Infection. Vaccines, 14(11), 991. https://doi.org/10.3390/vaccines14110991
Vancouver
Gurumani M, Kouamou V, Makadzange AT. HPV Infection in Sub-Saharan Africa: Circulating Genotypes, Vaccination Strategies (Single-Dose Versus Two-Dose), and Implications of HIV Co-Infection. Vaccines. 2026;14(11):991. doi:10.3390/vaccines14110991
BibTeX
@article{Gurumani2026,
author = {Gurumani, Margaret and Kouamou, Vinie and Makadzange, Azure Tariro},
title = {HPV Infection in Sub-Saharan Africa: Circulating Genotypes, Vaccination Strategies (Single-Dose Versus Two-Dose), and Implications of HIV Co-Infection},
journal = {Vaccines},
year = {2026},
volume = {14},
number = {11},
pages = {991},
doi = {10.3390/vaccines14110991}
}
EUVIMED